Prime Medicine (PRME) Current Assets (2021 - 2025)
Historic Current Assets for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $231.4 million.
- Prime Medicine's Current Assets fell 595.97% to $231.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.4 million, marking a year-over-year decrease of 595.97%. This contributed to the annual value of $211.9 million for FY2024, which is 4819.69% up from last year.
- According to the latest figures from Q3 2025, Prime Medicine's Current Assets is $231.4 million, which was down 595.97% from $121.3 million recorded in Q2 2025.
- In the past 5 years, Prime Medicine's Current Assets registered a high of $296.6 million during Q4 2022, and its lowest value of $121.3 million during Q2 2025.
- In the last 5 years, Prime Medicine's Current Assets had a median value of $214.8 million in 2024 and averaged $205.6 million.
- Its Current Assets has fluctuated over the past 5 years, first plummeted by 5179.79% in 2023, then soared by 4819.69% in 2024.
- Prime Medicine's Current Assets (Quarter) stood at $270.6 million in 2021, then increased by 9.62% to $296.6 million in 2022, then plummeted by 51.8% to $143.0 million in 2023, then soared by 48.2% to $211.9 million in 2024, then increased by 9.21% to $231.4 million in 2025.
- Its Current Assets stands at $231.4 million for Q3 2025, versus $121.3 million for Q2 2025 and $163.8 million for Q1 2025.